PMGC Holdings Inc.
ELAB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001840563
No open-market purchases or sales by PMGC Holdings Inc. insiders were filed in the last 90 days; 12 institutions reported holding it in 13F filings for Q2 2026, worth $322.5K in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by PMGC Holdings Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for PMGC Holdings Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Bensler Graydon | Chief Executive Officer | 3,036,437Indirect | Jun 3, 2026 | 1 |
| Parry Jeffrey | Director | – | Jun 3, 2026 | 1 |
| Daley Juliana | Director | – | Jun 2, 2026 | 1 |
| Braeden Lichti | Director | 3,336,437Indirect | Jun 2, 2026 | 1 |
| Kovalyov George | Director | – | Jun 2, 2026 | 1 |
| BWL Investments Ltd. | 10% Owner | 1,967,965 | Feb 1, 2024 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
No insider trades match these filters.